View Vaccine Information
Kentucky Healthcare Guidance
Healthcare Providers | Labs | Facilities
The COVID-19 response in Kentucky involves stakeholders at every level of the healthcare system. The following documents and links reflect the most current guidance for healthcare providers, laboratories and local public health.
COVID-19 Case Reporting
Note: The CDC/KDPH COVID-19 Case Report Form replaces the EPID 200 and CDC Case investigation form.
Vaccine Provider Enrollment
Please read the Vaccine Provider Enrollment Letter and Checklist prior to completing the registration.REGISTER
- Pfizer has 2 hotlines available for vaccine questions that are staffed 8 am-11 pm EST, 7 days a week.
- General Product Questions: storage & handling, basic dilution and administration 877-829-2619.
- Medical Information: efficacy, safety, stability, dosage, mechanism of action, and vaccine ingredients 800-438-1985.
- § Pfizer’s Shipping and Handling hotline will be staffed 8 am-8pm EST, 5 days a week. Shipping and Maintaining the Cold-Chain: dry ice, ordering, vaccine quantities, obtaining diluent 800-666-7248.
CDC Vaccine Toolkit – For Healthcare Providers
- CDC’s COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- CDC COVD-19 Vaccine Information
- Preparing for COVID-19 Vaccination
- What Healthcare Professionals Need to Know
- COVID-19 Vaccination Training Programs and Reference Materials
- Storage and Handling Toolkit
- COCA call: What Every Clinician Should Know about COVID-19 Vaccine Safety
- CDC Pfizer portal
- CDC Moderna portal
Lab Services Form To be completed by labs offering COVID-19 services.
COVID-19 Testing Services Contracts
Invoice Report (must be attached when submitting invoice)
Local Health Department Resources
Long Term Care Guidance
SAMHSA OTP Guidance: SAMHSA issued guidance allowing states with and without emergency declarations to allow Opioid Treatment Programs (OTPs) to provide 28 days of take-home medication to stable patients and 15 days of medication to less stable patients whom the OTP believes can responsibly manage this amount of medication.
SAMHSA 42 CFR Part 2 Guidance: SAMHSA issued guidance which allows providers to share patient SUD diagnosis information that would normally be protected under 42 CFR Part 2 in instances of a bona fide medical emergency. Usage of the medical emergency exception must be documented by providers.
CMS Guidance to Catastrophic Coverage Plans: CMS issued an FAQ clarifying that catastrophic coverage plans must include coverage of COVID-19 diagnosis and treatment under the Essential Health Benefits. CMS will waive enforcement actions against any such plan which provides COVID-19 services before patients pay the plan’s deductible, and encourages plans and states to provide such pre-deductible coverage.